Mwyngil Therapeutics
Mwyngil Therapeutics develops oral small-molecule therapies for metabolic, inflammatory, neuroinflammatory, and renal diseases.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
X account@Mwyngil · created Dec 22, 2025 (11 months old) · 2 followers
Website registeredOct 2, 2025 (14 months old)
TIMELINE · MILESTONES
Mwyngil Therapeutics | 266 days from website to first raise on record
One step per dated milestone. Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | — |
Timeline
- X account created
- Website created
Companies like Mwyngil Therapeutics
AAlzheon$100M Series B+ · Apr 2022
RRevier Therapeutics$6.95M Seed · Aug 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
AAlvara TherapeuticsPre Seed · Sep 2026
RRgenta TherapeuticsSeries B+ · Nov 2026
RRougeTx$58M Series A · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/mwyngil-therapeutics (get a free API key).